| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03096314 |
| P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2018-10-06 | |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 1360 | |
| P4844 | research intervention | (5R)-24,25-Dihydroxyvitamin D | Q27161510 |
| P6153 | research site | University of California, San Francisco | Q1061104 |
| Stanford University | Q41506 | ||
| Massachusetts General Hospital | Q126412 | ||
| Brigham and Women's Hospital | Q2900977 | ||
| Denver Health Medical Center | Q3023367 | ||
| Cleveland Clinic | Q4117596 | ||
| Baystate Medical Center | Q4874851 | ||
| Beth Israel Deaconess Medical Center | Q4897536 | ||
| Intermountain Medical Center | Q6047575 | ||
| Montefiore Medical Center | Q6905066 | ||
| Swedish Medical Center | Q7654755 | ||
| Tufts University School of Arts and Sciences | Q7851547 | ||
| University of Mississippi Medical Center | Q7895818 | ||
| Vanderbilt University Medical Center | Q7914455 | ||
| Maine Medical Center | Q50562367 | ||
| University of Utah Health Care | Q56582915 | ||
| University of Kentucky | Q1360303 | ||
| Indiana University – Purdue University Indianapolis | Q1433199 | ||
| University of California, Los Angeles | Q174710 | ||
| University of Virginia | Q213439 | ||
| Oregon Health & Science University | Q282097 | ||
| Ohio State University | Q309331 | ||
| P1813 | short name | VIOLET | |
| P580 | start time | 2017-04-27 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | Vitamin D to Improve Outcomes by Leveraging Early Treatment |
Search more.